Studies have found a dangerous connection between aspartame consumption and the development of brain tumors. When aspartame breaks down it produces a substance called DKP. As your stomach digests DKP, it produces a chemical that induces the growth of brain tumors.
I am finding contradiction here;QuoteStudies have found a dangerous connection between aspartame consumption and the development of brain tumors. When aspartame breaks down it produces a substance called DKP. As your stomach digests DKP, it produces a chemical that induces the growth of brain tumors.
Quote from: Numb Digger on January 28, 2015, 05:21:31 PMI am finding contradiction here;QuoteStudies have found a dangerous connection between aspartame consumption and the development of brain tumors. When aspartame breaks down it produces a substance called DKP. As your stomach digests DKP, it produces a chemical that induces the growth of brain tumors.Can't address it without a citation.
Quote from: HurtfulTurkey on January 28, 2015, 05:21:57 PMQuote from: Numb Digger on January 28, 2015, 05:21:31 PMI am finding contradiction here;QuoteStudies have found a dangerous connection between aspartame consumption and the development of brain tumors. When aspartame breaks down it produces a substance called DKP. As your stomach digests DKP, it produces a chemical that induces the growth of brain tumors.Can't address it without a citation.http://www.rense.com/general35/evid.htm
Altogether, our data show that NPI-2358 [a synthetic form of DPK] is a potent anti-tumor agent which is active in MDR tumor cell lines, and is able to rapidly induce tubulin depolymerization and monolayer permeability in HUVECs. These data warrant further evaluation of NPI-2358 as a vascular-disrupting agent in vivo. Currently, NPI-2358 is in preclinical development for the treatment of cancer.
Quote from: Numb Digger on January 28, 2015, 05:22:59 PMQuote from: HurtfulTurkey on January 28, 2015, 05:21:57 PMQuote from: Numb Digger on January 28, 2015, 05:21:31 PMI am finding contradiction here;QuoteStudies have found a dangerous connection between aspartame consumption and the development of brain tumors. When aspartame breaks down it produces a substance called DKP. As your stomach digests DKP, it produces a chemical that induces the growth of brain tumors.Can't address it without a citation.http://www.rense.com/general35/evid.htmThe amount of DKP absorbed from the breakdown of a serving of aspartame is negligible. In addition, DKP has been found to be useful in the drug industry because it can actually be used to break down tumors:http://www.ncbi.nlm.nih.gov/pubmed/16317287QuoteAltogether, our data show that NPI-2358 [a synthetic form of DPK] is a potent anti-tumor agent which is active in MDR tumor cell lines, and is able to rapidly induce tubulin depolymerization and monolayer permeability in HUVECs. These data warrant further evaluation of NPI-2358 as a vascular-disrupting agent in vivo. Currently, NPI-2358 is in preclinical development for the treatment of cancer.
Quote from: HurtfulTurkey on January 28, 2015, 05:32:05 PMQuote from: Numb Digger on January 28, 2015, 05:22:59 PMQuote from: HurtfulTurkey on January 28, 2015, 05:21:57 PMQuote from: Numb Digger on January 28, 2015, 05:21:31 PMI am finding contradiction here;QuoteStudies have found a dangerous connection between aspartame consumption and the development of brain tumors. When aspartame breaks down it produces a substance called DKP. As your stomach digests DKP, it produces a chemical that induces the growth of brain tumors.Can't address it without a citation.http://www.rense.com/general35/evid.htmThe amount of DKP absorbed from the breakdown of a serving of aspartame is negligible. In addition, DKP has been found to be useful in the drug industry because it can actually be used to break down tumors:http://www.ncbi.nlm.nih.gov/pubmed/16317287QuoteAltogether, our data show that NPI-2358 [a synthetic form of DPK] is a potent anti-tumor agent which is active in MDR tumor cell lines, and is able to rapidly induce tubulin depolymerization and monolayer permeability in HUVECs. These data warrant further evaluation of NPI-2358 as a vascular-disrupting agent in vivo. Currently, NPI-2358 is in preclinical development for the treatment of cancer.I wonder why there are so many contradicting studies. This is like fats all over again.
Can't wait until HT gets cancer from trusting government backed studies.